VALN – valneva se - american depositary shares (US:NASDAQ)

News

Valneva Reports Positive Final Phase 2 Antibody Persistence and Safety Results in Children for its Chikungunya Vaccine IXCHIQ®
Valneva (NASDAQ:VALN) was downgraded by analysts at Wall Street Zen
Valneva to Further Consolidate its Operations in France [Yahoo! Finance]
Valneva to Further Consolidate its Operations in France 
Valneva Announces Positive Final Phase 2 Results for Lyme Disease Vaccine Candidate
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com